Literature DB >> 11405835

Visual functioning and general health status in patients with uveitis.

R M Schiffman1, G Jacobsen, S M Whitcup.   

Abstract

OBJECTIVE: To measure the visual functioning and quality of life in patients with uveitis.
METHODS: Consecutive adult patients with noninfectious uveitis were enrolled. The Medical Outcomes Study 36-Item Short Form (SF-36) and the National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) were administered by a trained interviewer. Sociodemographic and clinical data were also collected.
RESULTS: Seventy-six patients were enrolled. The overall NEI VFQ-25 score was significantly lower among patients with uveitis than in a normal reference group (P<.001). The SF-36 physical (PCS) and mental (MCS) component summary scores were also significantly lower among patients with uveitis than in the general US population (P<.007). Among patients with uveitis, visual acuity, binocular involvement, intensity of therapy, employment status, and PCS and MCS scores were all significantly associated with overall NEI VFQ-25 scores in multivariable analysis. Medical comorbidity, ocular comorbidity, and NEI VFQ-25 scores were significantly associated with PCS scores. Medical comorbidity and NEI VFQ-25 scores were significantly associated with MCS scores. Regression models including NEI VFQ-25 scores explained an additional 7% of the variance in PCS scores and 16% of MCS scores. Models including both PCS and MCS scores explained an additional 12% of the variance in NEI VFQ-25 scores.
CONCLUSIONS: Patients with uveitis reported markedly poorer visual functioning and general health status than normal subjects. Patients with more severe uveitis have poorer visual functioning and general health status than patients with milder disease. Visual functioning and general health status measurement contribute complementary information and should both be performed in patients with uveitis to measure the effect of disease and its therapy on their quality of life.

Entities:  

Mesh:

Year:  2001        PMID: 11405835     DOI: 10.1001/archopht.119.6.841

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  42 in total

1.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

2.  Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease.

Authors:  Leorey N Saligan; Grace Levy-Clarke; Tongtong Wu; Lisa J Faia; Keith Wroblewski; Steven Yeh; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

3.  Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.

Authors:  Conor C Murphy; Kathrin Greiner; Jarka Plskova; N Andrew Frost; John V Forrester; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

4.  Quality of life and visual function in patients with intermediate uveitis.

Authors:  C C Murphy; E H Hughes; N A Frost; A D Dick
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

5.  Using the Effects of Youngsters' Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Courtney McCracken; Kirsten Jenkins; Daneka Stryker; Erica Myoung; Larry B Vogler; Kelly Rouster-Stevens; Scott R Lambert; Melanie J Harrison; Sampath Prahalad; Carolyn Drews-Botsch
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-11       Impact factor: 4.794

6.  Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.

Authors:  John Sheppard; Avani Joshi; Keith A Betts; Stacie Hudgens; Samir Tari; Naijun Chen; Martha Skup; Andrew D Dick
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

7.  Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis.

Authors:  Rupali K Naik; Katharine S Gries; Anne M Rentz; Jonathan W Kowalski; Dennis A Revicki
Journal:  Qual Life Res       Date:  2013-05-05       Impact factor: 4.147

8.  Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Kenneth W Griffin; Melanie J Harrison; Thomas J A Lehman; Traci Leong; Rachel Reeves Robb; Marla Shainberg; Lori Ponder; Phoebe Lenhart; Amy Hutchinson; Sunil K Srivastava; Sampath Prahalad; Scott R Lambert; Carolyn Drews-Botsch
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-09       Impact factor: 4.794

9.  Degree, duration, and causes of visual loss in uveitis.

Authors:  O M Durrani; N N Tehrani; J E Marr; P Moradi; P Stavrou; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.

Authors:  Traci E Clemons; Mark C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria Figueroa; Molly W Harrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.